A composition for treating controlling reducing or ameliorating inflammatory pain comprises a dissociated glucocorticoid receptor agonist ("DIGRA") a prodrug thereof a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable ester thereof. The composition can comprise an additional anti inflammatory agent and can be formulated for topical application injection or implantation. It may be used in a method of managing post surgical ocular pain such that it has lower risk of eliciting adverse side effects seen with other therapeutic agents.
